Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Dementia medications sits at the center of this dementia and brain health question.
Several medications can help reduce agitation in people with dementia, though none completely eliminate the behavior and each comes with tradeoffs. The most commonly prescribed medications for dementia-related agitation include antipsychotics (like risperidone and aripiprazole), antidepressants (particularly SSRIs like sertraline), anti-anxiety medications (such as buspirone), and in some cases, medications typically used for other conditions like divalproex. The choice depends on the person’s specific symptoms, overall health, other medications they take, and how their body responds to treatment. For example, a person with dementia who becomes aggressive and physically agitated might benefit from an antipsychotic, while someone whose agitation manifests as restlessness or verbal outbursts might respond better to an SSRI or behavioral interventions.
It’s important to understand that medications are just one tool in managing dementia-related agitation, and they work best when combined with non-medication strategies. Agitation in dementia often stems from pain, confusion, environmental triggers, infection, or unmet needs—so medication alone won’t address these root causes. A doctor will typically try to identify what’s driving the agitation before prescribing medication. Even when medication is appropriate, the goal is usually not to eliminate all agitation but to reduce it enough that the person can be more comfortable and safer, and that caregivers can provide better care without exhaustion.
Table of Contents
- Why Do Dementia Patients Experience Agitation and What Medications Help?
- Important Safety Concerns and Limitations of Dementia Agitation Medications
- How Different Medication Classes Work and What to Expect
- Medication Tradeoffs and When to Use Non-Medication Approaches First
- Medication Interactions and Complications in Older Adults with Dementia
- Monitoring and Adjusting Dementia Agitation Medications Over Time
- The Future of Dementia Agitation Management
- Conclusion
Why Do Dementia Patients Experience Agitation and What Medications Help?
Agitation in dementia happens because the disease damages brain areas that control emotions, memory, and impulse control. As dementia progresses, people lose the ability to communicate their needs clearly, understand their environment, or regulate their responses to frustration or fear. This often leads to behaviors like shouting, hitting, pacing, or restlessness. Medications can’t repair the damage, but they can adjust brain chemistry in ways that calm these behaviors—essentially lowering the emotional volume so the person is less reactive.
Antipsychotics like risperidone and quetiapine work by blocking dopamine and serotonin receptors in the brain, which reduces aggression, psychosis, and agitation. SSRIs like sertraline and citalopram increase serotonin levels, which can improve mood and reduce anxiety-driven agitation. Buspiron acts as a mild anti-anxiety agent without the sedation or addiction risk of benzodiazepines. Some doctors also use medications like divalproex (an anticonvulsant) or trazodone (a sedating antidepressant) off-label for agitation. For instance, a person with vascular dementia who becomes violent may find that a low dose of aripiprazole reduces their aggressive outbursts within two to three weeks, allowing more peaceful interactions with family and staff.
Important Safety Concerns and Limitations of Dementia Agitation Medications
One critical limitation is that the FDA has issued black box warnings for antipsychotics in older adults with dementia, specifically because these drugs increase the risk of stroke and death, particularly in people with vascular dementia. This doesn’t mean antipsychotics are never appropriate—only that they require careful monitoring, the lowest effective dose, and regular reassessment to ensure benefits outweigh risks. Additionally, antipsychotics can cause severe side effects including tardive dyskinesia (involuntary movement disorders), falls, sedation, weight gain, and metabolic changes like diabetes and high cholesterol. Another limitation is that medications often take weeks to show benefit.
If a caregiver expects immediate behavioral change, they may become discouraged or frustrated, potentially leading to dose increases when a slower approach would be safer. Some people with dementia develop tolerance to medications over time, meaning doses need adjustment, or the medication becomes less effective. There’s also the risk of over-medication: in some care settings, medications are used to manage staffing challenges rather than to genuinely help the person, leading to over-sedation and loss of function. A person on too much antipsychotic medication might sleep 16 hours a day, become unable to walk without assistance, or lose the ability to engage with family—this isn’t better care, it’s substituting one problem for another.
How Different Medication Classes Work and What to Expect
Antipsychotics are the most studied medications for dementia agitation, and they often work relatively well for people with psychotic symptoms (hallucinations, delusions) or severe aggression. However, they carry the highest risk profile. Risperidone, given at doses of 0.5 to 2 mg daily, typically shows effects within two to three weeks. Aripiprazole is sometimes preferred because it has a lower risk of stroke than risperidone, though it’s still not risk-free.
Quetiapine, given at 50 to 200 mg daily, is more sedating and may be chosen if sleep disturbance accompanies agitation. SSRIs take longer—often four to six weeks—to affect agitation, but they come with a lower risk profile and can also treat depression, which frequently coexists with agitation in dementia. Sertraline (50 to 100 mg daily) and citalopram (10 to 20 mg daily) are the most evidence-supported SSRIs for dementia; notably, citalopram has a recommended maximum dose of 20 mg daily in people over 60 due to heart rhythm risks at higher doses. Buspiron (15 to 30 mg daily) is mild and can take two to four weeks to work, but it’s very well tolerated and doesn’t increase fall risk the way antipsychotics do. For someone with early-stage dementia who becomes anxious and irritable, an SSRI combined with behavioral strategies might be a good first step before considering antipsychotics.
Medication Tradeoffs and When to Use Non-Medication Approaches First
The core tradeoff with dementia agitation medications is safety and side effects versus symptom control. Antipsychotics work faster and more powerfully than SSRIs, but they increase risks of stroke, falls, and death. SSRIs and buspiron are safer but may be insufficient for severe aggression or psychosis. Sedating medications like trazodone or quetiapine can calm agitation quickly but may deprive the person of meaningful participation in daily life.
Choosing a medication requires weighing what problem is most urgent: Is the person in danger of hurting themselves or others? Is their agitation driven by anxiety or pain? Are there environmental triggers that could be fixed without medication? This is why doctors and families should explore non-medication strategies first, or alongside medication. Agitation often improves dramatically with changes like consistent routine, calm environments, pain management, treatment of urinary tract infections, adequate sleep, engagement in activities the person enjoys, and validation of their feelings rather than confrontation. A person with dementia who is agitated may be in pain from arthritis, have a UTI, be frightened by a noisy environment, or be searching for a lost loved one—none of these improve with antipsychotics. Some research suggests that behavioral and environmental approaches prevent agitation in 60 to 80 percent of cases when applied thoughtfully. Only when these fail, or when agitation is severe and dangerous, does medication become the priority.
Medication Interactions and Complications in Older Adults with Dementia
Older adults with dementia typically take multiple medications for conditions like heart disease, diabetes, or hypertension, and dementia agitation medications can interact dangerously with these. SSRIs can interact with blood thinners, increasing bleeding risk. Antipsychotics can worsen orthostatic hypotension (sudden drop in blood pressure when standing), increasing fall risk. Medications that are sedating can worsen constipation, confusion, and urinary retention—common problems in dementia already. Someone on risperidone for agitation and metoprolol for heart disease, for example, might experience dangerous drops in blood pressure, leading to falls and fractures.
A significant limitation is that doctors sometimes don’t recognize when agitation is actually a medication side effect. A person might be sedated by an antipsychotic to the point of appearing confused or depressed, and instead of recognizing this as an adverse effect, the doctor adds an antidepressant or stimulant, compounding the problem. This polypharmacy—taking many medications—becomes its own risk. Regular medication reviews are essential but often don’t happen in busy clinical settings. Caregivers should watch for new or worsening confusion, excessive drowsiness, difficulty eating or swallowing, constipation, or sudden changes in blood pressure or heart rate, as these can signal medication complications.
Monitoring and Adjusting Dementia Agitation Medications Over Time
Once a medication is started, it needs ongoing monitoring. Initial check-ins should happen within one to two weeks to assess for side effects and tolerability, then again at four to six weeks to evaluate whether the medication is actually reducing agitation. If it’s not helping by six to eight weeks, the dose might be increased or a different medication tried. If it’s working but causing problems like excessive sedation or falls, the dose might be reduced or a different medication substituted.
A person who starts on 1 mg of risperidone for agitation and falls asleep 14 hours a day might be better served by dropping to 0.5 mg, trying a different medication like sertraline, or exploring whether an underlying cause like pain is being missed. Periodic reassessment is crucial because dementia changes over time and medication needs may shift. A medication that helped during one stage of illness might become less effective or more risky as the disease progresses. Some people can eventually discontinue agitation medications if behavioral and environmental strategies become effective, or if the agitation naturally decreases as the disease progresses (which sometimes happens, though not always). Family members and caregivers are the best source of information about whether a medication is actually helping because they see the person daily, so their input in these monitoring conversations is invaluable.
The Future of Dementia Agitation Management
Research is moving toward more targeted approaches that identify subtypes of agitation and match medications more precisely. Not all agitation is the same—some people are hyperactive and aggressive, others are withdrawn and irritable, others are afraid and defensive. Future treatment might involve genetic or biomarker testing to predict which person will respond best to which medication, rather than trial-and-error approaches.
There’s also growing focus on early identification and treatment of underlying causes: aggressive screening for infections, pain, medication side effects, and sleep disorders before turning to psychotropic medications. In parallel, there’s increasing emphasis on training caregivers and care facilities in behavioral and environmental modifications that can prevent or reduce agitation without medication. Dementia care is shifting toward person-centered approaches that honor the individual’s preferences, values, and communication style, recognizing that much “difficult behavior” is actually an attempt to communicate an unmet need. As this shift continues, medications will likely remain important tools for specific situations, but they’ll be one part of a more thoughtful, comprehensive approach to managing agitation.
Conclusion
Medications can help reduce agitation in people with dementia, but they’re tools with both benefits and serious risks. The most commonly prescribed medications—antipsychotics, SSRIs, and anti-anxiety agents—work through different mechanisms and carry different safety profiles. Antipsychotics work faster but increase the risk of stroke and death in older adults with dementia, while SSRIs are safer but slower and may not be sufficient for severe aggression. No medication works immediately, and all require careful monitoring for side effects and ongoing reassessment of effectiveness.
The best approach to managing agitation in dementia involves first understanding what’s causing it—pain, infection, confusion, fear, unmet needs, environmental triggers—and addressing those root causes through behavioral and environmental strategies. When these aren’t sufficient, medications can be valuable, but they should be prescribed at the lowest effective dose, monitored closely, and regularly reviewed to ensure they’re actually helping without causing more harm. If you or a loved one is dealing with dementia-related agitation, work with your doctor to develop a treatment plan that combines investigation of underlying causes, behavioral strategies, and careful consideration of medication as part of a comprehensive approach. Remember that managing agitation takes time and often involves some trial and error—patience and persistence in finding the right combination of strategies tends to yield better results than rushing to medication alone.
You Might Also Like
- Dementia and Sundowning: What Families Should Know
- Dementia and Hoarding Behavior
- Dementia and Aggression: What It May Mean
For more, see Alzheimer’s Association.
